Acute maintenance of perfusion in the absence of thrombospondin-1 or CD47
but not ApoE
Wild type TSP1 null CD47 null apoE null
50 min @ 5 min intervals
APOE-TOMMO40 Haplotypes And Alzheimer's Disease Phenotypes · APOE-TOMM40 haplotypes and Alzheimer’s disease phenotypes Dmitry Goldgaber 11, Alexander Vostrov* , Lon White2 1Psichiatry
Documents
Matrix mechanotransduction mediated by thrombospondin-1 ...
Cartilage Oligomeric Matrix Protein (COMP), Thrombospondin-4 …pub.epsilon.slu.se/1241/1/Thesisny.pdf · Cartilage Oligomeric Matrix Protein (COMP), Thrombospondin-4 (TSP-4) and
APOE Genotype Effects on Intrinsic Brain Network ...
Expression of Thrombospondin in the Adult Nervous System
Antibody therapy targeting the CD47 protein is effective ... · Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma Badreddin
Blockade of Thrombospondin-1-CD47 Interactions Prevents ...€¦ · FTSG survival. Remarkably, wild type FTSG survived on TSP1 null or CD47 null mice, indicating that TSP1 expression
APOE signaling in neurodegenerative diseases: an ...
Cartilage Oligomeric Matrix Protein (COMP), Thrombospondin ... · Cartilage Oligomeric Matrix Protein (COMP), Thrombospondin-4 (TSP-4) and type I and III Collagens in tendon – An
Loss of Thrombospondin Transcriptional Activityin Nickel
Roles of Thrombospondin-1 and -2 in Regulating Corneal and ...
hCD1Tg/HJ1Tg/ ApoE-/- ApoE Figure 4. Fatty acids do not show preferential accumulation in the skin of hCD1Tg/HJ1Tg/ApoE-/-mice and reactivity of lipids to a second mouse CD1b-autoreactive
Adrenalectomized APOE Knockout Mice Endotoxemia but Not ... fileLeukocytosis and Enhanced Susceptibility to Endotoxemia but Not Atherosclerosis in Adrenalectomized APOE Knockout Mice
Structure of human POFUT2: insights into thrombospondin ...emboj.embopress.org/content/embojnl/31/14/3183.full.pdf · Structure of human POFUT2: insights into thrombospondin type
macrophage-mediated destruction of small-cell CD47 ......Conflict of interest: The authors declare US patent applications pertaining to CD47-blocking therapies for human disease, including
APOE ɛ4, white matter hyperintensities, and cognition in ...
Purinergic signaling induces thrombospondin-1 expression ... · Purinergic signaling induces thrombospondin-1 expression in astrocytes Minh D. Tran and Joseph T. Neary* Research Service,
Supplementary Materials forSupplementary Materials for Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric